Alector shares plunge after dementia drug fails to slow disease progression – Reuters

1. Alector shares plunge after dementia drug fails to slow disease progression  Reuters
2. Alector’s dementia drug fails to slow patient decline in late-stage trial  statnews.com
3. Alector Announces Results from its Phase 3 Clinical Trial of Potential FTD-GRN Therapeutic  Yahoo Finance
4. Alector announces topline results from latozinemab phase 3 trial in individuals with frontotemporal dementia due to a GRN mutation and provides business update  MarketScreener
5. Peninsula biotech to lay off nearly half its staff after dementia drug fails in clinical trial  The Business Journals

Continue Reading